Trial Profile
Phase I Study of Cetuximab With RO4929097 in Metastatic Colorectal Cancer
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs RG 4733 (Primary) ; Cetuximab
- Indications Colorectal cancer
- Focus Adverse reactions
- 05 Jun 2013 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 05 Jun 2013 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 08 Jan 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.